A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
Public ClinicalTrials.gov record NCT01540864. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Study identification
- NCT ID
- NCT01540864
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- High Point Pharmaceuticals, LLC.
- Industry
- Enrollment
- 126 participants
Conditions and interventions
Conditions
Interventions
- HPP404 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2012
- Primary completion
- Apr 30, 2013
- Completion
- Apr 30, 2013
- Last update posted
- Sep 3, 2015
2012 – 2013
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 11 | Augusta | Georgia | 30909 | — |
| Site 3 | Valparaiso | Indiana | 46383 | — |
| Site 12 | Louisville | Kentucky | 40213 | — |
| Site 9 | Hyannis | Massachusetts | 02601 | — |
| Site 10 | Saint Paul | Minnesota | 55114 | — |
| Site 2 | New York | New York | 10065 | — |
| Site 1 | Charlotte | North Carolina | 28277 | — |
| Site 5 | High Point | North Carolina | 27265 | — |
| Site 7 | Norfolk | Virginia | 23502 | — |
| Site 6 | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01540864, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 3, 2015 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01540864 live on ClinicalTrials.gov.